Company Filing History:
Years Active: 2011-2013
Title: Ana Graf: Innovator in Alzheimer's Research
Introduction
Ana Graf is a prominent inventor based in Riehen, Switzerland. She has made significant contributions to the field of Alzheimer's research, focusing on innovative treatments for dementia. With a total of 3 patents, her work is paving the way for new therapeutic approaches.
Latest Patents
Ana Graf's latest patents include a composition comprising virus-like particles (VLP) and amyloid beta peptide. The first patent details novel uses of a construct consisting of VLP structure chemically coupled to a fragment of the A beta-1-42 peptide. This invention is particularly aimed at dosage regimens, modes of, and dosage forms for the administration of this construct for the treatment of patients suffering from dementia, especially Alzheimer's type dementia. The second patent reiterates similar uses of the VLP and amyloid beta peptide construct, emphasizing its potential in treating dementia.
Career Highlights
Ana Graf is currently associated with Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to focus on groundbreaking research that addresses critical health challenges related to neurodegenerative diseases.
Collaborations
Ana collaborates with esteemed colleagues such as Matthias Staufenbiel and Paolo Paganetti. Their combined expertise enhances the research efforts aimed at developing effective treatments for Alzheimer's disease.
Conclusion
Ana Graf's innovative work in the field of Alzheimer's research exemplifies the impact of dedicated inventors on healthcare advancements. Her contributions are vital in the ongoing battle against dementia, and her patents reflect a commitment to improving patient outcomes.